BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
HIV infection
,
Endothelial cell
,
Personalized medicine
,
Doxorubicin
,
rs7903146
,
PBX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
proteins P17
Summary
General Info
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Validation of a small molecule inhibitor of PDE6D-RAS interaction with favorable anti-leukemic effec…
Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216.
Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS Signaling.
The Major Ciliary Isoforms of RPGR Build Different Interaction Complexes with INPP5E and RPGRIP1L.
A homozygous PDE6D mutation in Joubert syndrome impairs targeting of farnesylated INPP5E protein to …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to…
To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17
A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheuma…
A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arth…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ